Regentis Biomaterials Ltd.
RGNT- Exchange
- NYSE
- Industry
- Orthopedic, Prosthetic & Surgical Appliances & Supplies
- SEC CIK
- 0001912966
No open-market purchases or sales by Regentis Biomaterials Ltd. insiders were filed in the last 90 days; 6 institutions reported holding it in 13F filings for Q2 2026, worth $2.98M in total; no superinvestor holds it.
Key figures
- Insider buysOpen market, last 90 days
- 0
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026, +3 vs. previous quarter
- 6
- 13F valueReported value at the end of Q2 2026
- $2.98M
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Superinvestors holding RGNT, Q2 2026
No superinvestor reported holding RGNT at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by Regentis Biomaterials Ltd. insiders from Form 4, newest first.
No open-market purchases or sales by Regentis Biomaterials Ltd. insiders are on file.
Top 10 13F holders, Q2 2026
The largest institutional positions in Regentis Biomaterials Ltd. at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Rosalind Advisors, Inc. | 701,685 | $2.48M | 0.93% | +450,175+179.0% | Added |
| Warberg Asset Management LLC | 86,980 | $306.2K | 0.09% | +86,980 | New |
| Jane Street Group, LLC | 43,333 | $153.0K | 0.00% | +43,333 | New |
| Renaissance Technologies LLC | 13,348 | $47.1K | 0.00% | +13,348 | New |
| UBS Group AG | 434 | $1.53K | 0.00% | +100+29.9% | Added |
| Tower Research Capital LLC (TRC) | 11 | $39 | 0.00% | +11 | New |